Literature DB >> 34218441

The Akt-mTORC1 pathway mediates Axl receptor tyrosine kinase-induced mesangial cell proliferation.

Yuxuan Zhen1, Tracy L McGaha2,3, Fred D Finkelman1,4, Wen-Hai Shao1.   

Abstract

Glomerulonephritis (GN), an important pathologic feature of many renal diseases, is frequently characterized by mesangial cell proliferation. We and others have previously shown that the TAM family receptor tyrosine kinases Axl, Mer, and Tyro-3 contribute to cell survival, proliferation, migration, and clearance of apoptotic cells (ACs); that Axl contributes to GN by promoting mesangial cell proliferation; and that small molecule inhibition of Axl ameliorates nephrotoxic serum-induced GN in mice. We now show that stimulation of renal mesangial cell Axl causes a modest increase in intracellular Ca2+ and activates NF-κB, mTOR, and the mTOR-containing mTORC1 complex, which phosphorylates the ribosomal protein S6. Axl-induction of Akt activation is upstream of NF-κB and mTOR activation, which are mutually codependent. Axl-induced NF-κB activation leads to Bcl-xl up-regulation. Axl is more important than Mer at mediating AC phagocytosis by mesangial cells, but less important than Mer at mediating phagocytosis of ACs by peritoneal macrophages. Taken together, our data suggest the possibility that Axl mediates mesangial cell phagocytosis of ACs and promotes mesangial cell proliferation by activating NF-κB and mTORC1. ©2021 Society for Leukocyte Biology.

Entities:  

Keywords:  Axl; NF-κB; TAM receptors; apoptotic cell clearance; mTORC1; mesangial cell proliferation

Mesh:

Substances:

Year:  2021        PMID: 34218441      PMCID: PMC9328168          DOI: 10.1002/JLB.2A1220-850RRR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   6.011


  37 in total

1.  Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages.

Authors:  Yuxuan Zhen; Wen-Hai Shao
Journal:  J Vis Exp       Date:  2019-05-24       Impact factor: 1.355

2.  Mechanism of inhibitory effect of warfarin on mesangial cell proliferation.

Authors:  M Yanagita; K Ishii; H Ozaki; H Arai; T Nakano; K Ohashi; K Mizuno; T Kita; T Doi
Journal:  J Am Soc Nephrol       Date:  1999-12       Impact factor: 10.121

3.  The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.

Authors:  J D Paccez; G J Vasques; R G Correa; J F Vasconcellos; K Duncan; X Gu; M Bhasin; T A Libermann; L F Zerbini
Journal:  Oncogene       Date:  2012-03-12       Impact factor: 9.867

4.  Essential role of Gas6 for glomerular injury in nephrotoxic nephritis.

Authors:  Motoko Yanagita; Yoshikazu Ishimoto; Hidenori Arai; Kojiro Nagai; Tsuyoshi Ito; Toru Nakano; David J Salant; Atsushi Fukatsu; Toshio Doi; Toru Kita
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 5.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

6.  The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Robert A Eisenberg; Philip L Cohen
Journal:  Clin Immunol       Date:  2009-07-24       Impact factor: 3.969

7.  Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.

Authors:  Han C Dan; Matthew J Cooper; Patricia C Cogswell; Joseph A Duncan; Jenny P-Y Ting; Albert S Baldwin
Journal:  Genes Dev       Date:  2008-06-01       Impact factor: 11.361

8.  Diversification of TAM receptor tyrosine kinase function.

Authors:  Anna Zagórska; Paqui G Través; Erin D Lew; Ian Dransfield; Greg Lemke
Journal:  Nat Immunol       Date:  2014-09-07       Impact factor: 25.606

9.  Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis.

Authors:  Sergey V Novitskiy; Rinat Zaynagetdinov; Georgii Vasiukov; Sergey Gutor; Wei Han; Ana Serezani; Anton Matafonov; Linda A Gleaves; Taylor P Sherrill; Vasiliy V Polosukhin; Timothy S Blackwell
Journal:  Oncotarget       Date:  2019-12-17

Review 10.  PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.

Authors:  Rui Liu; Youwen Chen; Guangzhi Liu; Chenxi Li; Yurong Song; Zhiwen Cao; Wen Li; Jinghong Hu; Cheng Lu; Yuanyan Liu
Journal:  Cell Death Dis       Date:  2020-09-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.